January 2, 2025— The latest announcement on the official website of China’s National Medical Products Administration (NMPA) revealed that the second New Drug Application (NDA...
Today, Shanghai Allist Pharmaceuticals Co., Ltd. (stock code: 688578) announced that Furmonertinib had been approved by the National Medical Products Administration (NMPA) of China...
On 25 November 2021, 3D Medicines (Beijing) Co., Ltd. (3DMed), Alphamab Oncology, and Simcere Pharmaceutical Group Limited (Simcere) jointly announced that Envafolimab (KN035), the...
Shanghai, China – March 19, 2020 – Hansoh Pharmaceutical Group Company Limited (“Hansoh Pharma”), a leading biopharmaceutical company in China, announced that the National Med...
Shanghai Office
Rm 208, Building 1, Universal Science & Technology Plaza, No. 958 Zhenbei Rd, Shanghai, China
Hanzhou Office
Rm 1802, Fl.18, Building 8, No. 19, Jugong Rd, Xixing Street, Binjiang District, Hangzhou, China
Jiaxing Office
Rm 406, Tigermed Building, No. 28 Huixin Rd, Daqiao Town, Nanhu District, Jiaxing, China
FAB Japan
8F, 1 Chome-5-1 Kanda Ogawamachi, Chiyoda City, Tokyo 101-0052
Follow Us
Home
Services
Telephone
Message